Welcome to Coulter Partners Global (English)

18 January 2024

Top hires for VC & PE portfolio companies Q4-2023

Search Highlights

Recent top global hires for Venture Capital and Private Equity portfolio companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.

This quarter’s successful placements include:

Function Focus area Location
CEO Reconstructive surgery Italy
CEO Medical devices Israel
CEO Immuno-oncology platform US
Chief Scientific Officer Gene therapies UK
Chief Business Officer Precision biotherapeutics Singapore
Chief Product Officer Medical information services UK
SVP Global Strategic Business Development Drug discovery services Germany
VP Drug Discovery & Preclinical Development CNS platform UK
Head of Clinical Operations Small molecule biopharma Denmark
Country Director Life sciences investor US
Head of Alliance Management Incubator UK
Chair Medical devices Israel
Chair Tech enabled care provider US
US-based Board Director T-cell therapies France

Newly opened projects include:

Function Focus area Location
CEO Small molecule biopharma Australia
CEO Synthetic biology technologies US
CEO Protein alternatives US
Chief Financial Officer Remote monitoring France
Chief Operating Officer Contract research services Germany
Chief Scientific Officer Gene therapies US
Chief of Staff Vaccines Denmark
Chief Business Officer Immuno-oncology platform UK
Head of Tech Ops & Manufacturing, UK Contract manufacturing services US
VP BD Cell Therapy Precision medicines UK
VP Regulatory Affairs & Quality Assurance, Europe Surgical devices US
Director Market Access & Pricing Europe Ophthalmology therapeutics Italy
Marketing & Communications Director AI for drug design France


A new version of Coulter Partners is available.